Cargando…
Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity
Autores principales: | Michel, Lars, Totzeck, Matthias, Rassaf, Tienush |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528736/ https://www.ncbi.nlm.nih.gov/pubmed/34671866 http://dx.doi.org/10.1007/s00395-021-00903-6 |
Ejemplares similares
-
Cardiotoxicity from immune checkpoint inhibitors
por: Michel, Lars, et al.
Publicado: (2019) -
Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer—a meta‐analysis
por: Michel, Lars, et al.
Publicado: (2020) -
Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies
por: Totzeck, Matthias, et al.
Publicado: (2022) -
Heart failure from cancer therapy: can we prevent it?
por: Totzeck, Matthias, et al.
Publicado: (2019) -
ECG Scoring for the Evaluation of Therapy-Naïve Cancer Patients to Predict Cardiotoxicity
por: Pohl, Julia, et al.
Publicado: (2021)